MCL1 and breast cancer: These preliminary studies suggest that Mcl-1 may support the escape of breast cancer cells from therapy-induced cell death (Figure 1C), suggesting that targeting Mcl-1 may be beneficial to improving the outcome of breast cancer patients, particularly those with Mcl-1 amplification [63].